tesaglitazar has been researched along with vildagliptin in 1 studies
| Studies (tesaglitazar) | Trials (tesaglitazar) | Recent Studies (post-2010) (tesaglitazar) | Studies (vildagliptin) | Trials (vildagliptin) | Recent Studies (post-2010) (vildagliptin) |
|---|---|---|---|---|---|
| 74 | 13 | 25 | 793 | 186 | 566 |
| Protein | Taxonomy | tesaglitazar (IC50) | vildagliptin (IC50) |
|---|---|---|---|
| Dipeptidyl peptidase 9 | Bos taurus (cattle) | 0.68 | |
| Dipeptidyl peptidase IV | Porphyromonas gingivalis | 1.3 | |
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.1496 | |
| Dipeptidyl peptidase 4 | Mus musculus (house mouse) | 0.051 | |
| Prolyl endopeptidase FAP | Homo sapiens (human) | 2.497 | |
| Dipeptidyl peptidase 8 | Homo sapiens (human) | 3.0627 | |
| Dipeptidyl peptidase 9 | Homo sapiens (human) | 0.4224 | |
| Dipeptidyl peptidase 2 | Homo sapiens (human) | 0.051 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lebovitz, H | 1 |
1 review(s) available for tesaglitazar and vildagliptin
| Article | Year |
|---|---|
Diabetes: assessing the pipeline.
Topics: Adamantane; Alkanesulfonates; Amyloid; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exenatide; Glycine; Humans; Hypoglycemic Agents; Indoles; Islet Amyloid Polypeptide; Maleimides; Nitriles; Oxazoles; Peptides; Phenylpropionates; Piperidines; PPAR alpha; PPAR gamma; Protein Kinase C; Pyrazoles; Pyrrolidines; Receptor, Cannabinoid, CB1; Receptors, Glucagon; Rimonabant; Venoms; Vildagliptin | 2006 |